[HTML][HTML] Impairment of the autophagy–lysosomal pathway in Alzheimer's diseases: pathogenic mechanisms and therapeutic potential
Abstract Alzheimer's disease (AD), the most common neurodegenerative disorder, is
characterized by memory loss and cognitive dysfunction. The accumulation of misfolded …
characterized by memory loss and cognitive dysfunction. The accumulation of misfolded …
[HTML][HTML] Impairment of the autophagy–lysosomal pathway in Alzheimer's diseases: Pathogenic mechanisms and therapeutic potential
W Zhang, C Xu, J Sun, HM Shen, J Wang… - Acta Pharmaceutica …, 2022 - ncbi.nlm.nih.gov
Abstract Alzheimer's disease (AD), the most common neurodegenerative disorder, is
characterized by memory loss and cognitive dysfunction. The accumulation of misfolded …
characterized by memory loss and cognitive dysfunction. The accumulation of misfolded …
Impairment of the autophagy-lysosomal pathway in Alzheimer's diseases: Pathogenic mechanisms and therapeutic potential
W ZHANG, XU Chengchao… - Acta Pharmaceutica …, 2022 - pesquisa.bvsalud.org
Alzheimer's disease (AD), the most common neurodegenerative disorder, is characterized
by memory loss and cognitive dysfunction. The accumulation of misfolded protein …
by memory loss and cognitive dysfunction. The accumulation of misfolded protein …
Impairment of the autophagy-lysosomal pathway in Alzheimer's diseases: Pathogenic mechanisms and therapeutic potential
W Zhang, C Xu, J Sun, HM Shen… - Acta pharmaceutica …, 2022 - pubmed.ncbi.nlm.nih.gov
Alzheimer's disease (AD), the most common neurodegenerative disorder, is characterized
by memory loss and cognitive dysfunction. The accumulation of misfolded protein …
by memory loss and cognitive dysfunction. The accumulation of misfolded protein …
[引用][C] Impairment of the autophagy–lysosomal pathway in Alzheimer's diseases: Pathogenic mechanisms and therapeutic potential
W Zhang, C Xu, J Sun, HM Shen, J Wang… - … Pharmaceutica Sinica B, 2022 - cir.nii.ac.jp
Impairment of the autophagy–lysosomal pathway in Alzheimer's diseases: Pathogenic
mechanisms and therapeutic potential | CiNii Research CiNii 国立情報学研究所 学術情報 …
mechanisms and therapeutic potential | CiNii Research CiNii 国立情報学研究所 学術情報 …
Impairment of the autophagy-lysosomal pathway in Alzheimer's diseases: Pathogenic mechanisms and therapeutic potential.
W Zhang, C Xu, J Sun, HM Shen, J Wang… - Acta Pharmaceutica …, 2022 - europepmc.org
Abstract Alzheimer's disease (AD), the most common neurodegenerative disorder, is
characterized by memory loss and cognitive dysfunction. The accumulation of misfolded …
characterized by memory loss and cognitive dysfunction. The accumulation of misfolded …
Impairment of the autophagy–lysosomal pathway in Alzheimer's diseases: Pathogenic mechanisms and therapeutic potential
W Zhang, C Xu, J Sun, HM Shen, J Wang, C Yang - 2022 - repository.um.edu.mo
Abstract Alzheimer's disease (AD), the most common neurodegenerative disorder, is
characterized by memory loss and cognitive dysfunction. The accumulation of misfolded …
characterized by memory loss and cognitive dysfunction. The accumulation of misfolded …
Impairment of the autophagy-lysosomal pathway in Alzheimer's diseases: Pathogenic mechanisms and therapeutic potential
W ZHANG, C XU, J SUN, HM SHEN… - Acta Pharmaceutica …, 2022 - pesquisa.bvsalud.org
ABSTRACT Alzheimer's disease (AD), the most common neurodegenerative disorder, is
characterized by memory loss and cognitive dysfunction. The accumulation of misfolded …
characterized by memory loss and cognitive dysfunction. The accumulation of misfolded …
Impairment of the autophagy-lysosomal pathway in Alzheimer's diseases: Pathogenic mechanisms and therapeutic potential.
W Zhang, C Xu, J Sun, HM Shen, J Wang… - Acta Pharmaceutica …, 2022 - europepmc.org
Abstract Alzheimer's disease (AD), the most common neurodegenerative disorder, is
characterized by memory loss and cognitive dysfunction. The accumulation of misfolded …
characterized by memory loss and cognitive dysfunction. The accumulation of misfolded …